CATXNYSEPharmaceutical PreparationsFiscal year ends December 31

Perspective Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$2.19+0.02 (+0.92%)

Close on Oct 19, 2026

Market cap: $264.23M
P/E (TTM): –
Dividend yield: –

Perspective Therapeutics, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30	FY 2010 2010-06-30
Cash & Equivalents	31	62	56	64	2.39	5.33	2.60	6.11	10	5.23	7.68	2.90	2.67	2.11	1.68
Short-Term Investments	114	165	0	0	–	–	0.83	3.04	2.25	9.36	10	–	–	–	–
Cash & Short-Term Investments	145	227	56	64	2.39	5.33	3.43	9.15	13	15	18	2.90	2.67	2.11	1.68
Receivables	0.01	0.12	1.61	2.01	2.04	1.15	1.19	0.73	0.61	1.05	0.91	0.92	0.87	0.79	–
Inventory	–	–	1.40	0.98	0.65	0.53	0.49	0.32	0.33	0.40	0.36	0.41	0.44	0.75	–
Prepaid Expenses & Other	3.65	4.13	0.44	0.48	0.43	0.31	0.34	0.27	0.30	0.26	0.21	0.20	0.14	0.14	–
Other Current Assets	0.04	0.08	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	–	–
Total Current Assets	148	231	59	67	5.51	7.32	5.45	10	14	16	19	4.44	4.14	4.22	–
Property, Plant & Equipment	77	57	1.98	1.96	1.74	1.61	1.31	1.05	0.58	0.57	1.02	1.68	2.42	3.21	–
Gross Property, Plant & Equipment	83	60	9.47	9.21	9.25	8.98	8.98	8.65	8.12	7.69	7.57	7.61	7.60	7.55	–
Accumulated Depreciation	-6.20	-2.96	-7.50	-7.25	-7.52	-7.37	-7.67	-7.59	-7.54	-7.11	-6.55	-5.92	-5.18	-4.34	–
Machinery & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	3.13	3.05	–
Construction in Progress	–	–	–	–	–	–	–	–	–	–	–	–	–	0.12	–
Long-Term Investments	–	–	–	–	–	–	–	0	2.97	5.11	5.40	–	–	–	–
Equity Method Investments	0.12	0.13	0	0	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Right-of-Use Assets	1.50	2.22	0.51	0.77	1.00	–	–	–	–	–	–	–	–	–	–
Goodwill	–	0	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	0.36	0.28	0.11	0.13	0.14	0.16	0.20	0.23	0.15	0.20	0.22	0.22	0.20	0.20	–
Other Long-Term Assets	0.49	0.41	0.11	0.13	0.14	0.16	0.20	0.23	0.15	0.25	0.26	0.28	0.30	0.28	–
Total Assets	267	341	64	70	8.70	9.42	7.46	12	18	23	27	7.06	7.51	7.89	–
Accounts Payable	21	10	0.97	0.73	0.65	0.68	1.39	0.63	0.61	0.50	0.57	0.43	0.39	0.37	–
Current Portion of Leases	0.62	0.96	0.27	0.25	0.24	–	–	–	–	–	–	–	–	–	–
Other Current Liabilities	–	–	0.12	0.10	0.09	0.07	0.04	0.13	0.18	0.13	0.14	0.10	0.05	0.11	–
Total Current Liabilities	29	18	2.27	1.80	1.58	1.12	1.84	1.11	1.09	1.09	1.15	0.79	0.65	0.77	–
Long-Term Debt	1.57	1.63	–	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Leases	1.01	1.43	0.26	0.52	0.77	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	1.63	2.39	0.52	0.78	1.01	–	–	–	–	–	–	–	–	–	–
Deferred Tax Liabilities	1.70	2.50	–	–	–	–	–	–	–	–	–	–	–	–	–
Other Long-Term Liabilities	0.39	0.06	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	60	50	3.16	3.01	2.98	1.74	2.43	1.67	1.70	2.22	2.59	1.69	1.69	1.44	–
Total Debt	1.57	1.63	–	–	–	–	–	–	–	–	–	–	–	–	–
Preferred Stock	0	0	0	0	–	–	–	–	–	0.00	0.00	0.00	0.00	–	–
Common Stock	0.07	0.07	0.14	0.14	0.07	0.07	0.06	0.06	0.06	0.05	0.05	0.03	0.03	0.03	–
Additional Paid-In Capital	542	522	160	159	94	92	84	83	83	82	82	57	54	51	–
Retained Earnings	-335	-232	-99	-91	-88	-84	-79	-73	-66	-62	-58	-52	-48	-45	–
Treasury Stock	–	–	–	–	–	–	–	–	0	-0.01	-0.01	-0.01	-0.01	-0.01	–
Comprehensive Income & Other	0.11	-0.05	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	207	291	61	67	5.72	7.68	5.03	11	16	21	24	5.37	5.82	6.45	6.20
Total Equity	207	291	61	67	5.72	7.68	5.03	11	16	21	24	5.37	5.82	6.45	6.20
Total Liabilities & Equity	267	341	64	70	–	9.42	7.46	12	18	23	27	7.06	7.51	7.89	–
Shares Outstanding(shares)	74	71	14	14	6.89	6.74	5.63	5.50	5.50	5.50	5.47	3.46	3.10	2.64	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -41.4%

Financial strength

Current ratio: 6.61
Debt to equity: 0.00
Debt to assets: 0.4%
Cash to current liabilities: 132.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: 0.82
Dividend yield: –